Replies to post #259259 on Amarin Corp Plc (AMRN)

[Pharmacydude]

Hikma is going full steam ahead. Planning to launch even if verdict is appealed.

Hikma is working closely with the U.S. Food and Drug Administration (FDA) to gain approval for its Abbreviated New Drug Application (ANDA) for its generic version of Vascepa®. The company is evaluating its options for launching the product following FDA approval, including an at-risk launch in the event the District Court's decision is appealed.


https://www.prnewswire.com/news-releases/hikma-confirms-favourable-ruling-in-generic-vascepa-patent-suit-301032237.html